Abstract: An apparatus for producing carbon nanotubes includes a plasma apparatus and a CVD reactor which are connected in series is disclosed, and a nanoparticle catalyst in an aerosol state prepared in the plasma apparatus is transferred into the CVD reactor to synthesize carbon nanotubes, thereby continuously synthesizing the carbon nanotubes having excellent physical properties.

Abstract: A composition for removing edge beads from metal-containing resists, and a method of forming patterns including a step of removing edge beads using the composition are provided. The composition for removing edge beads includes an additive including at least one selected from among phosphoric acid, a phosphorous acid-based compound, and a hypophosphorous acid-based compound, and a carboxylic acid-based compound, and an organic solvent, where a mixed weight ratio of the at least one selected from among the phosphoric acid, the phosphorous acid-based compound, and the hypophosphorous acid-based compound to the carboxylic acid-based compound is about 9:1 to about 1.2:1.

Abstract: A sound control device and a method for controlling the sound control device in a vehicle. The method comprises obtaining an error signal indicating residual noise in the vehicle, and an audio signal; calculating magnitudes of low frequency components of the error signal; adjusting magnitudes of low frequency components of the audio signal according to the magnitudes of the low frequency components of the error signal; and outputting the adjusted audio signal through a speaker.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: A gate driver including a plurality of stages, each of the plurality of stages including an eighth transistor connected between a third power input terminal and an output terminal, the eighth transistor including a gate electrode connected to a fourth node, a seventh transistor connected between a second power input terminal and the output terminal, the seventh transistor including a gate electrode connected to a third node, an eleventh transistor connected between the third power input terminal and the fourth node, the eleventh transistor including a gate electrode connected to a first node, a twelfth transistor connected between the first node and the third node, the twelfth transistor including a gate electrode connected to the second power input terminal, and a third capacitor connected between the third power input terminal and the fourth node.

Abstract: The present invention relates to a battery pack that may reduce risks caused by a large amount of gas. In addition, the present invention may provide a battery pack that discharges a gas but prevents internally generated flames from being exposed to the outside. In addition, the present invention may provide an electric device including one or more battery packs.

Abstract: Disclosed herein are a pharmaceutical composition for prevention, alleviation, or treatment of any disease selected from the group consisting of type 2 diabetes mellitus, hyperinsulinemia, impaired glucose tolerance disorder, and insulin resistance disorder, wherein the pharmaceutical composition includes a GPR40 agonist and an SGLT2 inhibitor, the GPR40 agonist being a compound represented by Formula 1, a racemate of the compound, an enantiomer of the compound, a diastereomer of the compound, or a pharmaceutically acceptable salt of the compound, the racemate, the enantiomer or the diastereomer, a method of preparing the same, and a method of treating type 2 diabetes mellitus and the like using the same.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating Charcot-Marie-Tooth disease associated with a peripheral nervous system, comprising a compound represented by formula I, optical isomers thereof or pharmaceutically acceptable salts thereof as an active ingredient, a method for preventing or treating Charcot-Marie-Tooth disease associated with the peripheral nervous system using the compound, a use of the compound for preventing or treating Charcot-Marie-Tooth disease associated with the peripheral nervous system, and a use of the compound in preparing a medicament for preventing or treating Charcot-Marie-Tooth disease associated with the peripheral nervous system.

Abstract: This disclosure is directed to methods and systems that establish a secure data channel between a host and a disaggregated hardware device (“DHD”) of a data center. The system comprises an initiator host that runs objects, such as virtual machines and containers. The host includes an initiator smart network interface card (“SNIC”). The initiator SNIC includes a virtual device, a trust platform module (“TPM”) and a security engine. The system also comprises a target host equipped with a DHD and a target SNIC. The target SNIC includes a TPM and a security engine. The TPM and the security engine of the initiator SNIC and the TPM and the security engine of the target SNIC establish a secure data channel between an object running on the host and the DHD.

Abstract: A method of a terminal for transmitting channel state information for one or more beams comprises the steps of: determining whether group-based beam reporting is configured based on channel state information (CSI) reporting configuration information; measuring reference signal received power (RSRP) for one or more channel state information reference signals (CSI-RS) received through one or more CSI-RS resources; and transmitting, to a base station, the channel state information including a value in a table configured in advance based on whether the group-based beam reporting is configured and one or more CSI-RS RSRP measurement results obtained by the measurement.

Abstract: A vehicle such as an electric vehicle may include a battery such as a secondary battery that includes an electrode manufactured using a dry process. A system for evaluating a dry electrode mixture of the battery includes an electrical conductivity measurement device configured to measure electrical conductivity of the dry electrode mixture, and an analysis device configured to evaluate the dry electrode mixture based on the measured electrical conductivity.

Abstract: Disclosed is a composition containing 2?-FL for ameliorating, preventing or treating diseases caused by reduction of dopamine. 2?-FL has an advantage of effectively preventing or treating diseases caused by a decrease in dopamine by effectively suppressing degeneration of dopaminergic neurons. In particular, the composition of the present invention is effective in preventing, treating, or ameliorating Parkinson's disease caused by reduction of dopamine because it contains 2?-fucosyllactose (2?-FL) as an active ingredient, thereby suppressing the decrease in dopaminergic neurons and exhibiting an effect of improving motor activity.

Abstract: A method of controlling a portable device including first and second touch screens is provided. The method includes displaying first information related to a first application on the first touch screen and displaying second information related to the first application on the second touch screen; receiving a first user input moving to the first touch screen on the second touch screen; and replacing the first information and the second information with a third information and a fourth information related to the first application on the first and second touch screens, in response to receiving the first user input, wherein each of the third information and the fourth information is displayed while being slidden from the second touch screen to the first touch screen and the third information is displayed over a boundary between the first and second screens during the sliding of the third and fourth information.

Abstract: A display device includes: a substrate; a first bank including a first sub-bank and a second sub-bank spaced apart from each other on the substrate; a first electrode on the first sub-bank; a second electrode on the second sub-bank and spaced apart from the first electrode; and a light-emitting element between the first sub-bank and the second sub-bank. Each of the first and second sub-banks has a first area having a concave curved shape in a cross section and being adjacent to the light-emitting element. The first electrode has a first section extending beyond the first sub-bank toward the light-emitting element, the second electrode has a first section extending beyond the second sub-bank toward the light-emitting element, and a width of the first section of the first electrode is different from a width of the first section of the second electrode.

Abstract: A method for managing storage of materials implemented in an electronic device to ensure that earliest-stored materials are removed from storage positions, first controls a scanning device to scan batch code and obtains batch information of the material when an inlet of the electronic device is required to receive the batch of material. A serial number of a storage position is associated with the batch information and a storage time of the batch of material in the storage position is recorded. The serial number of the storage position storing the batch of material according to the batch information is determined when a material-request is received and a transmission track is controlled to transfer the batches of material which having earliest recorded storage times one by one to the outlet, so as to release the batches of material from the storage position.

Abstract: The present disclosure provides a method for surface modification of a titanium implant material and a titanium implant obtained by the method for surface treatments. A titanium implant according to one embodiment of the present disclosure has high bond strength between implant and bone and its corrosion resistance.

Abstract: A holographic waveguide includes a light guide unit configured to guide lights; a first holographic optical element disposed on one surface or the other surface of the light guide unit and configured to diffract an input light; a second holographic optical element disposed on any one of the one surface and the other surface, and configured to receive a light diffracted by the first holographic optical element and to direct a part of the received light to the other one of the one surface and the other surface; a third holographic optical element disposed on a surface, and configured to receive diffracted lights by the second holographic optical element and to guide the lights; and a fourth holographic optical element configured to receive a diffracted light by the third holographic optical element, and to allow the light to be output from the light guide unit.

Abstract: A vehicle such as an electric vehicle may include a battery such as a secondary battery that includes an electrode manufactured using a dry process. A system for evaluating a dry electrode mixture of the battery includes a manufacturing apparatus configured to form a film of the dry electrode mixture, the dry electrode mixture being a mixture of an electrode active material, a conductive additive, and a binder, a microscope configured to obtain a target image of the dry electrode mixture supplied from the manufacturing apparatus, and a computer operably connected to the microscope, the computer configured to analyze the target image obtained from the microscope and determine whether the binder in the dry electrode mixture is fiberized.

Abstract: A substrate treatment method includes an auto-recovery operation of automatically recovering a substrate when a treatment process of treating the substrate is interrupted due to an occurrence of an abnormality and a chamber neutralization operation of neutralizing an inside of a process chamber including the substrate before the auto-recovery operation after the treatment process is stopped.